Difference between revisions of "Template:Current week ecosystem agenda"

Revision as of 09:44, 6 November 2023

Oroboros declares solidarity against the Russian aggression-war in Ukraine and against all aggression-wars worldwide. - »More details

-» A future for Ukraine is the future of its science

2023 Week 45

Nov- 06 Mo

Nov- 07 Tu

How often should I re-assemble the O2k-chamber?

We recommend disassembling, cleaning and re-assembling the O2k-chamber at least every 1-2 years. It is also necessary to disassemble it when there is persistent biological or protein contamination, medium leakage from the chamber, an oxygen leak of the chamber, or an unstable or unexpectedly high or low oxygen signal.
- »O2k-chamber assembly - possible problems« and »O2k-Videosupport: Insert O2k-chamber«
- communicated by »Timon-Gomez Alba« and »Schmitt Sabine«

Nov- 08 We

Nov- 09 Th

Nov- 10 Fr

When should I analyze my data as flux control ratios (FCRs)?

FCRs enable the comparison of samples normalized with various mitochondrial content parameters or when sample concentration is unknown. This is achieved by internally normalizing O₂ fluxes in different respiratory states to the maximum flux in a common reference state.
- »Flux control ratio«
- communicated by »Baglivo Eleonora« and »Timon-Gomez Alba«

Next Week

2023 Week 46

Nov- 13 Mo

Nov- 14 Tu - World Diabetes Day

"Liver [mitochondria] (...) adapt to metabolic challenges by increasing FAO-derived mitochondrial respiration in OBES [obesity model] and NASH [non-alcoholic steatohepatitis model], but by increasing both FAO- and TCA-derived respiration in DIAB [diabetes model]."

Dewidar B, Mastrototaro L, Englisch C, Ress C, Granata C, Rohbeck E, Pesta D, Heilmann G, Wolkersdorfer M, Esposito I, Reina Do Fundo M, Zivehe F, Yavas A, Roden M (2023) Alterations of hepatic energy metabolism in murine models of obesity, diabetes and fatty liver diseases. »Bioblast link«

from the O2k-Network »DE Duesseldorf Roden M« and »DE Cologne Pesta D«

Nov- 15 We

Nov- 16 Th - World Pancreatic Cancer Day

"To the advantage of PDAC [pancreatic ductal adenocarcinoma] patients, innovative and more effective therapeutics will be possible with a greater understanding of how pancreatic cancer cells control mitochondrial metabolism."

Padinharayil H, Rai V, George A (2023) Mitochondrial metabolism in pancreatic ductal adenocarcinoma: from mechanism-based perspectives to therapy. »Bioblast link«

Nov- 17 Fr

---

@@ Line 1: / Line 1: @@
 {{Template:Science for Ukraine}}
-Week 44
-*'''Oct- 30 Mo'''
-----
-*'''Oct- 31 Tu'''
-:{|
-| width="110" align="center" | [[File:MitoPedia.jpg|left|80px|MitoPedia|link=MitoPedia]]
-|''' How to interpret cytochrome ''c'' efficiency '''<br>
-Stimulation of OXPHOS or ET capacity upon addition of cytochrome ''c''  provides evidence of cytochrome ''c'' loss, indicating damage of the mitochondrial outer membrane, which could be caused by sample preparation or pathological conditions. <br>
-- »'''[https://wiki.oroboros.at/index.php/Cytochrome_c_control_efficiency Cytochrome ''c'' control efficiency]'''« <br>
-- communicated by »[[Schmitt Sabine]]« and »[[Leo Elettra]]«
-|}
-----
-*'''Nov- 01 We'''
-----
-*'''Nov- 02 Th'''
-----
-*'''Nov- 03 Fr'''
-:{|
-| width="100" align="center" |[[Image:O2k-Publications.jpg|70px|link=http://wiki.oroboros.at/index.php/O2k-Publications:_Topics |O2k-Publications in the MiPMap]]
-|'''"Peripheral impairments at the skeletal muscle level, namely reduced mitochondrial function and the presence of markers of impaired mitochondrial biogenesis emerged as major determinants of exercise intolerance and fatigue [in patients with post-acute sequelae of SARS-CoV-2 infection]"''' <br>
-* Colosio M, Brocca L, Gatti M, Neri M, Crea E, Cadile F, Canepari M, Pellegrino MA, Polla B, Porcelli S, Bottinelli R (2023) Structural and functional impairments of skeletal muscle in patients with post-acute sequelae of SARS-CoV-2 infection. [[Colosio 2023 J Appl Physiol (1985)|»Bioblast link«]]
-|}
-----
-'''<big>Next Week</big>'''
 Week 45
@@ Line 55: / Line 27: @@
 |}
 ----
+'''<big>Next Week</big>'''
+Week 46
+*'''Nov- 13 Mo'''
+----
+*'''Nov- 14 Tu''' - World Diabetes Day
+:{|
+| width="100" align="center" |[[Image:O2k-Publications.jpg|70px|link=http://wiki.oroboros.at/index.php/O2k-Publications:_Topics |O2k-Publications in the MiPMap]]
+|'''"Liver [mitochondria] (...) adapt to metabolic challenges by increasing FAO-derived mitochondrial respiration in OBES [obesity model] and NASH [non-alcoholic steatohepatitis model], but by increasing both FAO- and TCA-derived respiration in DIAB [diabetes model]."''' <br>
+* Dewidar B, Mastrototaro L, Englisch C, Ress C, Granata C, Rohbeck E, Pesta D, Heilmann G, Wolkersdorfer M, Esposito I, Reina Do Fundo M, Zivehe F, Yavas A, Roden M (2023) Alterations of hepatic energy metabolism in murine models of obesity, diabetes and fatty liver diseases. [[Dewidar 2023 EBioMedicine|»Bioblast link«]]
+:from the O2k-Network »[[DE Duesseldorf Roden M]]« and »[[DE Cologne Pesta D]]«
+|}
+----
+*'''Nov- 15 We'''
+----
+*'''Nov- 16 Th''' - World Pancreatic Cancer Day
+:{|
+| width="100" align="center" |[[Image:O2k-Publications.jpg|70px|link=http://wiki.oroboros.at/index.php/O2k-Publications:_Topics |O2k-Publications in the MiPMap]]
+|'''"To the advantage of PDAC [pancreatic ductal adenocarcinoma] patients, innovative and more effective therapeutics will be possible with a greater understanding of how pancreatic cancer cells control mitochondrial metabolism."''' <br>
+* Padinharayil H, Rai V, George A (2023) Mitochondrial metabolism in pancreatic ductal adenocarcinoma: from mechanism-based perspectives to therapy. [[Padinharayil 2023 Cancers (Basel)|»Bioblast link«]]
+|}
+----
+*'''Nov- 17 Fr'''
+---